Tolerability of NGX-4010, a capsaicin 8% dermal patch, following pretreatment with lidocaine 2.5%/prilocaine 2.5% cream in patients with post-herpetic neuralgia
Open Access
- 19 December 2011
- journal article
- Published by Springer Science and Business Media LLC in BMC Anesthesiology
- Vol. 11 (1), 25
- https://doi.org/10.1186/1471-2253-11-25
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Capsaicin Dermal PatchDrugs, 2010
- Long-Term Safety of NGX-4010, a High-Concentration Capsaicin Patch, in Patients with Peripheral Neuropathic PainJournal of Pain and Symptom Management, 2010
- EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revisionEuropean Journal of Neurology, 2010
- TRPV1 Agonist Approaches for Pain ManagementPublished by Wiley ,2010
- Treatment of Neuropathic Pain: An Overview of Recent GuidelinesThe American Journal of Medicine, 2009
- A Randomized, Double-Blind Comparison of Two Topical Anesthesic Formulations Prior to Electrodesiccation of Dermatosis Papulosa NigraDermatologic Surgery, 2008
- Neuropathic painNeurology, 2008
- Direct Comparison of EMLA versus Lidocaine for Pain Control in Nd:YAG 1,064 nm Laser Hair RemovalDermatologic Surgery, 2006
- Effect of EMLA Pre-treatment on Capsaicin-induced Burning and HyperalgesiaActa Dermato-Venereologica, 1999
- Postherpetic Neuralgia — Pathogenesis, Treatment, and PreventionThe New England Journal of Medicine, 1996